Syracuse, UT, United States of America

J Kevin Day

This inventor holds 1 USPTO granted patent. Top assignee: Epigenomics Ag. Active years: 2015.


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: J Kevin Day: Innovator in Gene Expression Analysis

Introduction

J Kevin Day is a notable inventor based in Syracuse, UT (US). He has made significant contributions to the field of gene expression analysis, particularly in relation to prostate cell proliferative disorders. His work is characterized by a focus on innovative methods and nucleic acids that enhance the understanding of gene expression.

Latest Patents

J Kevin Day holds 1 patent for his invention titled "Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders." This patent provides methods and nucleic acids for the detection of and differentiation between prostate cell proliferative disorders. The invention is achieved through the analysis of the expression status of a panel of genes or subsets thereof.

Career Highlights

Throughout his career, J Kevin Day has been associated with Epigenomics AG, a company that focuses on the development of innovative diagnostic solutions. His expertise in gene expression analysis has positioned him as a key figure in the field, contributing to advancements in medical diagnostics.

Collaborations

J Kevin Day has collaborated with notable colleagues, including Susan Cottrell and Yreka Ocampo. These collaborations have further enriched his research and development efforts in the area of gene expression.

Conclusion

J Kevin Day's contributions to the field of gene expression analysis are significant and impactful. His innovative methods and dedication to research continue to advance the understanding of prostate cell proliferative disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…